Discontinued — last reported Q2 '21
Roivant Sciences Gain (loss) on deconsolidation of subsidiary remained flat by 0.0% to $2.76M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.3%, from $3.11M to $2.76M. Over 3 years (FY 2021 to FY 2025), Gain (loss) on deconsolidation of subsidiary shows an upward trend with a 29.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A gain indicates a successful divestiture or strategic restructuring, while a loss may signal a distressed exit or asset impairment.
This represents the accounting gain or loss recognized when a company loses control of a subsidiary, often due to a sale...
Highly specific to corporate strategy and M&A activity; not a standard recurring operational metric.
gain_loss_on_subsidiary_deconsolidation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $5.04M | $16.76M | $12.51M | $0.00 | $17.35M | $0.00 | $15.42M | $0.00 | $0.00 | $0.00 | $3.11M | $2.76M | $2.76M | $2.76M | $2.76M |
| QoQ Change | — | — | — | — | +232.5% | -25.3% | -100.0% | — | -100.0% | — | -100.0% | — | — | — | -11.3% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | — | — | +3.5% | -100.0% | — | — | -100.0% | — | -79.8% | — | — | — | -11.3% |